AstraZeneca (AZN) Short Positions
Add to Alert listActive Short Positions
| Holder | Position | Change | Date | |
|---|---|---|---|---|
| No active short positions | ||||
Historical Short Positions
| Holder | Position | Change (%) | Date | |
|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 0.01% | 21-Jul-2021 | View History | |
| HBK Investments L.P. | 0% | 21-Jul-2021 | View History | |
| Millennium International Management LP | 0.03% | 21-Jul-2021 | View History | |
| Millennium International Management LP | 2.08% | 20-Jul-2021 | View History | |
| Millennium International Management LP | 0.53% | 15-Jul-2021 | View History | |
| HBK Investments L.P. | 0.51% | 30-Apr-2021 | View History | |
| Farallon Capital Management, L.L.C. | 0.6% | 23-Apr-2021 | View History | |
| Farallon Capital Management, L.L.C. | 0.5% | 14-Apr-2021 | View History |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.
Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
Latest directors dealings
- 11 hours ago Alphawave IP Group
- 12 hours ago WH Smith
- 12 hours ago Staffline Group
- 13 hours ago Manchester & London Investment Trust
- 13 hours ago Associated British Foods